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Abstract
We have previously reported that Porphyromonas gingivalis infection of gingival epithelial cells (GEC) requires an exogenous
danger signal such as ATP to activate an inflammasome and caspase-1, thereby inducing secretion of interleukin (IL)-1b.
Stimulation with extracellular ATP also stimulates production of reactive oxygen species (ROS) in GEC. However, the
mechanism by which ROS is generated in response to ATP, and the role that different purinergic receptors may play in
inflammasome activation, is still unclear. In this study, we revealed that the purinergic receptor P2X4 is assembled with the
receptor P2X7 and its associated pore, pannexin-1. ATP induces ROS production through a complex consisting of the P2X4,
P2X7, and pannexin-1. P2X72mediated ROS production can activate the NLRP3 inflammasome and caspase-1. Furthermore,
separate depletion or inhibition of P2X4, P2X7, or pannexin-1 complex blocks IL-1b secretion in P. gingivalis-infected GEC
following ATP treatment. However, activation via P2X4 alone induces ROS generation but not inflammasome activation.
These results suggest that ROS is generated through stimulation of a P2X4/P2X7/pannexin-1 complex, and reveal an
unexpected role for P2X4, which acts as a positive regulator of inflammasome activation during microbial infection.
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Introduction
Innate immunity is the first line of defense used by the host
against microbial infection. In human tissues, epithelial cells play a
major role in innate immunity. Epithelial cells can not only form
physical barriers, but also secrete inflammatory cytokines and
chemokines in response to infection following recognition of
microbial products by pattern-recognition receptors (PRRs), such
as Toll-like receptors (TLR) and Nod-like receptors (NLR) [1–4].
The proinflammatory cytokines IL-1b and IL-18 have been
linked to atherosclerosis, systemic inflammatory diseases, and
autoimmune disease. Their expression and secretion are strin-
gently controlled by pathogen-associated molecular patterns
(PAMPs) and danger signals [5–7]. Some PAMPs like lipopoly-
saccharide (LPS), peptidoglycan, lipoteichoic acid, flagellin, and
microbial nucleic acids induce pro-IL-1b and pro-IL-18 expres-
sion and intracellular accumulation [8,9]. However, the matura-
tion and secretion of these cytokines requires a danger signal like
ATP or uric acid crystal, which comes from stressed or infected
cell and leads to the activation of inflammasomes [10–13].
Inflammasomes are large multiprotein complexes that act as a
caspase-1-activating platform for IL-1b and IL-18 maturation.
They can be categorized by the composition of their integral PRR
family member, which acts as a scaffold protein that contributes to
caspase-1 recruitment, clustering, and auto-activation [12–17].
The best characterized inflammasome is the NLRP3 inflamma-
some. It contains NLRP3 as a scaffold protein, an apoptosis-
associated speck-like protein containing a caspase recruitment
domain (ASC) adaptor, and caspase-1 [18,19]. Danger-associated
molecular patterns (DAMPs), such as extracellular ATP, can
activate the NLRP3 inflammasome through ATP-gated P2X7 ion
channels [11,12,20]. Upon ATP stimulation, the P2X7 receptor
opens a cation channel, which permits K+ efflux, and gradually
forms a larger pore on the membrane by recruiting the
hemichannel pannexin-1 to activate the NLRP3 inflammasome
[21–23]. Although P2X4 is also an ATP-gated ion channel, it has
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not been previously described to participate in ATP-mediated
caspase-1 activation.
Several downstream mechanisms have been proposed to induce
NLRP3 inflammasome activation, including reactive oxygen
species (ROS) production, lysosomal destabilization, K+ efflux,
and apoptosis [12,24–26]. In particular, ATP stimulation of cells
has been shown to induce caspase-1 activation following ROS
production, and treatment with the P2X7 antagonist, oxATP,
attenuates ATP-induced ROS generation [12,27–32]. In addition
to P2X7 agonists, agonists of other purinergic receptors also
promote ROS generation, implying that other purinergic recep-
tors may also contribute to ATP-induced ROS production
[31,33,34]. However, until now, no other purinergic receptor
has been implicated in ATP-induced activation of the NLRP3
inflammasome other than P2X7.
Gingival epithelial cells (GEC) represent the first barrier to
infection and are a prominent component of the innate immune
system in the oral cavity. The GEC are also targets of infection,
and can be infected by common periodontopathogens such as
Porphyromonas gingivalis, Tannerella forsythia, and Actinobacillus actino-
mycetemcomitans [35–38]. Previously, we showed that P. gingivalis-
infected GEC overexpress pro-IL-1b, but secretion of the cytokine
requires a second stimulus, such as treatment with exogenous
ATP, to activate caspase-1 through the NLRP3 inflammasome
[34,39]. Characterizing the cell signaling events activated by
pathogens in GEC provides potential candidates to control
inflammatory responses associated with periodontal disease.
However, the molecular mechanisms by which the GEC respond
to bacterial infections remain to be elucidated. Thus, we here
investigate which purinergic receptors contribute to ATP-induced
ROS production and inflammasome activation in GEC, and
reveal an unexpected modulatory role for P2X4.
Materials and Methods
Cells and Chemical Reagents
Porphyromonas gingivalis ATCC 33277 was cultured anaerobically
for 24 h at 37uC in trypticase soy broth (TSB) supplemented with
yeast extract (1 mg/ml), hemin (5 mg/ml) and menadione (1 mg/
ml) and used for infection as described [34].
The human immortalized gingival keratinocyte (HIGK) cell line
[40], was obtained as previously described [40,41]. Cells were
cultured in serum-free defined keratinocyte-SFM (Gibco) at 37uC
in a humidified incubator containing 5% CO2.
Primary GEC were obtained after oral surgery from healthy
gingival tissue as previously described [42]. Cells were cultured as
monolayers in serum-free keratinocyte growth medium (KGM)
(Lonza) at 37uC in 5% CO2. Primary GEC were used for
experimentation at ,75–80% confluence and cultured for 24 h or
Figure 1. ROS production in response to ATP in GEC. (A) Immortalized GEC (HIGK) were treated for 1 hour with 3 mM ATP or left untreated as a
control and stained with DCF (green) to detect ROS by fluorescence microscopy. Hoechst (blue) was used to stain nuclei. (B) ROS generation was
measured with DCF at the indicated time points after 3 mM ATP stimulation. The mean fluorescence was quantified by image J and normalized for
the number of cells. (C) Quantification of ROS production induced by different nucleotides. GEC were treated with 3 mM of ATP, ADP, AMP, or UTP, or
left untreated for 1 hour, and analyzed by image J as in (B). The bars show the average values and SD of three independent experiments.
doi:10.1371/journal.pone.0070210.g001
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48 h before infection with P. gingivalis at a multiplicity of infection
(M.O.I.) of 100 [34].
ATP, ADP, UTP, oxATP, PPADS, and probenecid were from
Sigma-Aldrich. AMP was from Santa Cruz Biotech. 5-BDBD was
from Tocris Bioscience. All primers were purchased from Fisher
Scientific. Antibodies against P2X4 (APR-002) and P2X7 (APR-
008) were obtained from Alomone Labs.
RNA Extraction, Reverse Transcription PCR, and
Quantitative PCR
Total RNA was isolated from 106 HIGK cells using RNeasy
Mini kit (Qiagen) according to the manufacturer’s protocol. cDNA
was amplified from 2 mg RNA by random hexamers using
TagMan Reverse Transcription Reagents kit (Applied Biosystems).
The following primers were used in PCR: 59-
CGCCTTCCTCTTCGAGTATGA-39 and 59-AGA-
TAACGCCCACCTTCTTATTACG-39 for P2X1; 59-
GCCTACGGGATCCGCATT-39 and 59-TGGTGGGAAT-
CAGGCTGAAC-39 for P2X2; 59-GCTGGACCATCGG-
GATCA-39 and 59-GAAAACCCACCCTACAAAGTAGGA-39
for P2X3; 59-CCTCTGCTTGCCCAGGTACTC-39 and 59-
CCAGGAGATACGTTGTGCTCAA-39 for P2X4; 59-
CTGCCTGTCGCTGTTCGA-39 and 59-GCAGGCC-
CACCTTCTTGTT-39 for P2X5; 59-AGGC-
CAGTGTGTGGTGTTCA-39 and 59-TCTCCACTGGGCAC-
CAACTC-39 for P2X6; 59-
Figure 2. Synergistic effects of NADPH oxidase and mitochondria in ROS production. (A) HIGK were pretreated with 50 mM DPI for 30
minutes followed by 3 mM ATP stimulation, and stained with DCF (green) or MitoSOX (red) to detect ROS by fluorescence microscopy. (B) The
fluorescence was quantified in three independent experiments as in Figure 1.
doi:10.1371/journal.pone.0070210.g002
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Figure 3. Involvement of P2X4, P2X7, and pannexin-1 in ATP-mediated ROS generation. (A) Total RNA from immortalized GEC was
extracted and reversed transcribed (RT) to cDNA. The cDNA was used to perform PCR with the primers specific for the indicated genes, and the PCR
products were finally visualized by EtBr staining. (B) GEC were treated with 100 mM or 3 mM ATP as indicated for 1 hour, and ROS production was
measured with DCF staining and visualized by fluorescence microcopy. Quantification of the fluorescence in three independent experiments with SD
is shown in (C). (D–E) ROS production was measured by DCF staining in GEC stimulated under different conditions. GEC were left untreated or
stimulated with 20 mM nigericin or 3 mM ATP for 1 hour followed by fluorescence microscopy. Diminished ROS generation by different receptor
antagonists was examined by pretreating cells with 100 mM oxATP for 30 minutes, 1 mM probenecid for 10 minutes, or 50 mM 5-BDBD or 100 mM
PPADS for 15 minutes, followed by 3 mM ATP stimulation for 1 hour.
doi:10.1371/journal.pone.0070210.g003
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Figure 4. Diminished ATP-induced ROS production due to depletion of P2X4 or P2X7 by RNA interference. (A) Immortalized GEC were
transduced with lentiviruses carrying the indicated shRNA-expressing plasmid for 1 day and selected with puromycin. After selection, cells were
collected and total RNA was analyzed by qPCR to confirm knockdown efficiency. (B) DCF staining of ROS production after 3 mM ATP stimulation for 1
hour in different cell lines. The fluorescence shown in (C) was quantified as in Figure 1 and normalized to shCtrl, which was transduced with control,
non-mammalian shRNA.
doi:10.1371/journal.pone.0070210.g004
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TCTTCGTGATGACAAACTTTCTCAA-39 and 59-
GTCCTGCGGGTGGGATACT-39 for P2X7; and 59-GGTGA-
GACAAGACCCAGAGC-39 and 59-GGCATCGGACCTTA-
CACCTA-39 for pannexin1.
The PCR cycling protocol for all primers was 94uC at 5 s, 55uC
at 5 s and 68uC at 15 s. The protocol was repeated for 40 cycles
and included an initial 5 min enzyme activation step at 94uC and
a final 10 min extension step at 72uC. PCR products were
separated by electrophoresis on a 2% agarose gel and visualized by
ethidium bromide staining.
Quantitative PCR (qPCR) was carried out with 1/50 of the
cDNA preparation in the Mx3000P (Stratagene) in 25 ml final
volumes with the Brilliant QPCR Master Mix (Stratagene). cDNA
was amplified using 200 nM of each specific sense and antisense
primers. Quantitative PCR was conducted at 95uC for 10 min,
followed by 40 cycles at 95uC for 30 s, 55uC for 1 min and 72uC
for 30 s. The expression levels of P2X4, P2X7, and pannexin-1
were normalized to GAPDH by the comparative cycle threshold
method, as described by the manufacturer (Stratagene). The
primers for the genes coding P2X4, P2X7, and pannexin-1 were as
above. For GAPDH, the primers were: 59-TTAAAAG-
CAGCCCTGGTGAC-39 and 59-
CTCTGCTCCTCCTGTTCGAC-39.
Lentiviral Infection of HIGK Cells
Immortalized GEC (HIGK) stably expressing shRNA against
P2X4 (TRCN0000044960 and TRCN0000044962), P2X7
(TRCN0000045095 and TRCN0000045097), and pannexin-1
(TRCN0000156046 and TRCN0000155348) were generated by
transducing the cells with lentiviral particles purchased from
Sigma-Aldrich. Transduction was performed following the man-
ufacturer’s instructions. Nontarget shRNA control cells were also
generated using an irrelevant sequence (SHC002V, Sigma).
Briefly, GEC were plated at 70% confluency 24 h prior to
transduction, and the corresponding lentiviral transduction
particles were added at M.O.I. of 3 overnight. Fresh media was
added the next day, and stably infected cells were selected by
addition of media containing 5 mg/ml puromycin (Sigma-Aldrich).
Transient RNA Depletion with Sirna in Primary GEC
Expression of P2X4 and P2X7 in primary GEC was repressed
with different siRNA sequences as previously described [43]. The
siRNA sequences were: 59-GCUUUCAACGGGUCUGUCATT-
39 and 59-UGACAGACCCGUUGAAAGCTA-39 for P2X4
(Ambion, LifeCell Technologies, S9957, Cat. #: 4392420); and
59-ACAAUGUUGAGAAACGGACUCUGAT-39 for P2X7 (27
mer siRNA duplexes OriGene Technologies, Cat. #: SR303325).
Briefly, cells were treated with siRNA using Glycofect Transfec-
tion Reagent (Kerafast) mixed with 10 nM siRNA (stock
concentration of siRNA was 20 nM) in a total volume of 100 ml.
Four hours later, new cell-medium was added to the cells without
removal of the transfection mixture, and cells were incubated for
36 hours. qPCR was performed to confirm the knockdown
efficiency and specificity, as previously shown [44].
ROS Measurement
ROS measurement was assayed with the ROS indicator dyes,
CM-H22DCFDA DCF and MitoSOX (Invitrogen), as described
previously [43,45]. In brief, cells were loaded with 2.5 mMDCF or
5 mM MitoSOX in PBS for 30 min at 37uC, washed with PBS,
and treated with 100 mM or 3 mM ATP for 1 h at 37uC. Cells
were counter-stained with Hoechst33342 in order to reveal the
nucleus. Finally, the cells were observed by wide-field fluorescence
microscope (Leica, Deerfield, IL).
Measurement of Caspase-1 Activation by ELISA
GEC were treated with 100 mM or 3 mM ATP for 3 h and
supernatants were collected and subjected to human caspase-1
immunoassay (R&D) according to manufacturer’s instructions. In
brief, the caspase-1 ELISA uses monoclonal and polyclonal
antibodies specific for the caspase-1 p20 subunit as capture and
detection antibodies, respectively. One hundred ml of supernatant
were first mixed with 50 ml of RD1W buffer and loaded onto
caspase-1 monoclonal antibody coated-wells for 1.5 hrs. One
hundred ml of caspase-1 antiserum was then used as detection
antibodies. Anti-rabbit IgG-HRP conjugate was used for quanti-
fication. Activated caspase-1 was measured using a plate reader at
450 nm with wavelength correction at 540 nm.
Figure 5. Impaired ATP-stimulated caspase-1 activation due to
disruption of the complex containing P2X4, P2X7, and pan-
nexin-1. (A) Immortalized GEC that had been depleted of P2X4 or P2X7
using lentiviral particles were treated with 100 mM or 3 mM ATP for 3
hours, and supernatants were collected for caspase-1 activity measure-
ment. Caspase-1 activity was measured by ELISA as described in
Material and Methods. (B) Total proteins isolated from GEC were
subjected to immunoprecipitation (IP) by a polyclonal anti-P2X4
antibody or Dynabeads as a control. Precipitates or total protein
extract (as input) were resolved on SDS-PAGE and analyzed on
immunoblots with anti-P2X7 (top), anti-pannexin-1 (middle), or anti-
P2X4 (bottom) antibodies.
doi:10.1371/journal.pone.0070210.g005
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Figure 6. Abrogation of ATP-induced IL-1b secretion in P. gingivalis-infected GEC by inhibition of P2X4, P2X7, or pannexin-1. Primary
GEC (C and D) and immortalized GEC (A and B) were infected with or without P. gingivalis (P.g.) at an M.O.I. of 100 for 6 hours, followed by treatment
with different pharmaceutical agents. Infected cells were treated with 100 mM ATP, 3 mM ATP, 3 mM ADP, 3 mM AMP, or 3 mM UTP individually for 1
P2X4 Modulates ATP-Induced Inflammasome Activation
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Measurement of IL-1b Secretion by ELISA
Secretion of IL-1b was measured using a commercial cytokine
ELISA kit (BD Biosciences Pharmingen) as described [39].
Co-Immunoprecipitation of Purinergic Receptors
Co-immunoprecipitation was performed with Dynabeads (In-
vitrogen) according to the manufacturer’s instructions. Cells were
lysed with the extraction buffer, and cell extracts were incubated
for 3 h at 4uC with beads pre-coupled overnight with P2X4
antibody. Precipitates were washed with extraction buffer and
LWB with the use of a magnet and were subjected to 2X sample
buffer and heated to 99uC for 10 min. The eluted proteins were
analyzed by Western blot as previously described [46].
Results
ATP Induces ROS Generation in GEC
It has been shown stimulation with ATP results in high levels of
ROS generated in alveolar macrophages and primary GEC
[27,34]. In order to characterize ATP-induced ROS production in
GEC, we used a stable GEC cell line, the human immortalized
gingival keratinocyte cell line (HIGK) [40], stained with carboxy-
H2DCFDA (DCF), which remains nonfluorescent until its
deacetylation and oxidation. Fluorescence microscopy images
showed a significant increase of DCF fluorescence in 3 mM ATP
stimulated HIGK cells (Figure 1A). Quantitative analysis of
fluorescence microscopy data showed that the fluorescence in
ATP-treated cells was about 9 times higher than in cells without
treatment. Furthermore, the cells responded quickly to ATP
stimulation within 5 minutes and reached a steady state from 30
minutes to at least 3 hours (Figure 1, B and C). Treatment with
other extracellular nucleotides such as ADP, AMP, or UTP was
unable to induce significant ROS generation in the cells
(Figure 1C). These results suggest that stimulation with ATP,
unlike other nucleotides, can induce ROS production in GECs.
Synergistic Effects of NADPH Oxidase and Mitochondria
During ROS Generation
Two possible sources of ROS that activate the inflammassome
have been described. One may be due to activation of
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase,
triggered by frustrated phagocytosis [47]. The other may due to
the main intracellular source of ROS, the mitochondria [30].
Recent studies have uncovered the existence of cross-talk between
the NADPH oxidase and mitochondria [48]. In GECs, it was
demonstrated that ATP induces both cytosolic and mROS
production (Choi, 2013). To verify whether NADPH oxidase-
induced ROS by ATP may modulate mROS production in GECs,
we measured ATP-induced mROS generation after inhibiting
NADPH oxidase with diphenyleneiodonium chloride (DPI), which
was previously shown to block caspase-1 activation [49]. As shown
in Figure 2A and B, DPI profoundly attenuated ATP-triggered
cytosolic ROS production, as detected by DCF, confirming that
ATP treatment induces ROS through NADPH oxidase. To
examine if NADPH oxidase could also modulate ATP-induced
mROS production, we used MitoSOX to detect superoxide in
mitochondria. Quantitative analysis of fluorescence micrographs
confirmed that ATP treatment also triggers mROS production, in
agreement with previous results [45]. The increase of mROS can
be partially inhibited by DPI, implying that NADPH oxidase plays
a significant role in mROS generation (Figure 2, A and B). Taken
together, these results suggest that ATP-induced NADPH
activation can synergistically promote mROS production in
GECs.
hour (A and C). Alternatively, infected cells were pre-treated with 50 mM 5-BDBD for 15 minutes, 100 mM PPADS for 15 minutes, 100 mM oxATP for 30
minutes, or 1 mM probenecid for 10 minutes, followed by treatment with 3 mM ATP for 1 hour (B and D). The supernatants were collected and
subjected to ELISA to measure IL-1b secretion. (E) Primary GEC were transfected with siRNA sequences against P2X4 or P2X7 for one day, and mRNA
levels were detected by qPCR. (F) Primary GEC depleted of P2X4 or P2X7 were infected with P. gingivalis (P.g.) and treated with probenecid and 3 mM
ATP as shown in (B). IL-1b secretion in the supernatants was analyzed by ELISA. The values showed averages and SD from duplicate samples, which
were obtained from three separate experiments.
doi:10.1371/journal.pone.0070210.g006
Figure 7. Model showing the role of P2X4 and P2X7 in ROS production and inflammasome activation in GEC stimulated with
extracellular ATP.
doi:10.1371/journal.pone.0070210.g007
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Purinergic Receptors Involved in ATP-induced ROS
Generation
It has been proposed that extracellular ATP induces ROS
production through ligation of the ATP-gated P2X7 ion channel,
in association with the pore-forming hemi-channel, pannexin-1, in
macrophages and neurons [19,21,50]. To investigate whether
ATP-induced ROS production in GEC takes place through P2X7,
we examined the gene expression levels of purinergic receptors in
HIGK cells. In agreement with our previous description of
primary GEC [51], the HIGK cells express P2X1 throuh P2X7. In
addition, the HIGK cells express pannexin-1 (Figure3A).
P2X- and pannexin-1-dependent responses in HIGK cells were
next examined by fluorescence microscopy (Figure 3B). Consistent
with previous results, 3 mM ATP stimulated a large level of ROS
production, suggesting that ATP mediates ROS production
through P2X7 ligation (Figure 3, B and C). A role for P2X7 was
further confirmed by showing that ATP-induced ROS production
was inhibited by pretreatment with the P2X7 and pannexin-1
antagonists, oxATP and probenecid, respectively (Figure 3D).
Moreover, as illustrated in Figure 3E, treatment with the selective
P2X7 antagonist, PPADS, significantly blocked ATP-induced
ROS generation. These data suggest that P2X7 may be involved
in ATP-induced ROS generation in GEC.
Unexpectedly, treatment with 100 mM ATP also elicited ROS
generation but to a lower extent than with 3 mM ATP (Figure 3,
A and B). P2X4 is considered to mediate high affinity responses to
ATP stimulation, at lower concentrations than for P2X7
[31,33,52,53]. Thus, these results suggested that P2X4 may be
involved in ATP-mediated ROS production. To test this
possibility, we pretreated cells with the potent P2X4 antagonist,
5-BDBD. As shown in Figure 3E, pretreatment with 5-BDBD
significantly blocked ATP-induced ROS generation. Taken
together, these results suggest that ATP may elicit ROS generation
through P2X4 and P2X7 ligation in GEC.
Confirmation by RNA Interference for Role of P2X7, P2X4
and Pannexin-1 in ATP-Mediated ROS Production
As inhibitor studies suggested that P2X4 may be involved in
ATP-dependent ROS responses, we examined this unexpected
result by stably depleting P2X4, P2X7 and pannexin-1 by lentiviral
delivery of specific shRNA. Specific cepletion efficiency in each
cell line was validated individually by qPCR, as we have previously
done to show specific depletion of purinergic receptors by RNA
interference [44]. As shown in Figure 4A, the mRNA levels of
P2X4, P2X7, and pannexin-1 were reduced by at least ,70% in
comparison to cells transduced with control shRNA virus particles.
Depletion was specific, as P2X4 depletion did not affect P2X7
expression, and conversely, P2X7 depletion did not affect P2X4
expression (not shown). In agreement with Figure 3, depletion of
P2X7 or pannexin-1 resulted in attenuation of ROS production
after ATP stimulation, compared to GEC transduced with control
shRNA. Although depletion of P2X4 by RNA interference was less
efficient than for P2X7, P2X4 depletion resulted in a dramatic
decrease in ATP-mediated ROS production (Figure 4, B and C).
Collectively, these findings indicate that both P2X4 and P2X7
contribute to ROS generation after ATP treatment of GEC.
ATP Ligation by P2X4/P2X7/Pannexin-1 Complex Leads to
Inflammasome Activation in GEC
We previously showed that ATP treatment of GEC leads to
NLRP3 inflammasome activation [39]. As ROS production has
been associated with inflammasome and caspase-1 activation
[12,27,29,30], we evaluated whether ATP-mediated caspase-1
activation in GEC takes place through P2X4/P2X7 ligation. Using
ELISA to measure secretion of activated caspase-1, we observed
that treatment of GEC with 100 mM ATP was insufficient for
caspase-1 activation, even though ROS generation was induced.
In contrast, 3 mM ATP treatment resulted in high levels of
caspase-1 activation in GEC stably-expressing the control shRNA
(Figure 5A); but the activation of caspase-1 by 3 mM ATP
treatment was abrogated when either P2X4 or P2X7 were depleted
in GEC (Figure 5A). Thus, treatment with 3 mM ATP induced
ROS production via the P2X4/P2X7 complex and activated the
NLRP3 inflammasome. However, 100 mM ATP stimulation
induced ROS generation through P2X4 ligation, but stimulation
with this concentration of ATP was not sufficient to activate the
inflammasome.
The non-redundant roles of P2X4 and P2X7 in ATP-induced
ROS generation led us to hypothesize that P2X4 and P2X7 may
be associated in the membrane and function as a physical complex
in ATP-mediated responses in GEC. Therefore, we examined
physical associations between P2X4 and P2X7 in GEC by
performing co-immunoprecipitation experiments. After precipitat-
ing endogenous P2X4 using an anti-P2X4 antibody, we observed
that P2X7 and pannexin-1 were detected in the immunoprecip-
itate (Figure 5B). Taken together, these data indicate that P2X4,
P2X7, and pannexin-1 form a heterocomplex in GEC, and play
non-redundant roles in ATP-induced ROS generation.
ATP Ligation of P2X4/P2X7/Pannexin-1 Contributes to
Secretion of pro-inflammatory Cytokines Secretion in
Primary GEC Infected with P. gingivalis
Previously we had reported that infection of GEC with P.
gingivalis leads to expression of pro-IL-1b and its accumulation
within the infected cell. However, secretion of IL-1b requires a
second signal, such as the danger signal ATP, in order to activate
the NLRP3 inflammasome and caspase-1, allowing processing and
secretion of the mature IL-1b [39].
Given the unexpected observation that P2X4 can modulate
ATP-dependent caspase-1 activation in the immortalized HIGK
cells, we examined whether a similar effect could be observed in
immortalized (HIGK) cells and primary GEC during infection
with P. gingivalis. As in our previous studies, neither P. gingivalis
infection alone nor infection combined with 100 mM ATP
treatment could induce IL-1b secretion by HIGK cells. Only
infected cells treated with 3 mM ATP, but not other nucleotides,
could promote Il-1b secretion (Figure 6A). Similarly, using
primary GEC, we found that ATP, but not other nucleotides,
could promote IL-1b secretion by infected cells (Figure 6C). We
also consistently observed that primary GEC produce and secrete
higher levels of IL-1b than HIGK cells (Figure 6).
Furthermore, pretreatment of infected HIGK or primary GEC
with the P2X7 antagonists, PPADS and oxATP, blocked ATP-
dependent IL-1b secretion. In addition, the pannexin-1 inhibitor,
probenecid, also abrogated IL-1b secretion. Finally, inhibition of
P2X4 by 5-BDBD reduced the amount of IL-1b secretion, even
though the cells were treated with 3 mM ATP, which stimulates
signaling via P2X7 (Figure 6B and D).
To further confirm a role for P2X4 and P2X7 in IL-1b, we used
siRNA to deplete P2X4 and P2X7 in primary GEC individually.
(In our hands, siRNA treatment is more effective than shRNA
delivery for RNA interference in primary GEC.) Figure 6E
showed that P2X4 or P2X7 mRNA levels were depleted with an
efficiency of over 80% in primary GEC. Similarly to our previous
results [39], P. gingivalis infection followed by 3 mM ATP
treatment caused IL-1b secretion by the primary GEC that had
been treated with control siRNA. However, depletion of P2X4 or
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P2X7 reduced significantly IL-1b secretion, which again showed a
non-redundant role for P2X4 and P2X7 in ATP-dependent IL-1b
secretion. Probenecid treatment prior to ATP stimulation
repressed even further the IL-1b secretion in P2X4 and P2X7
knockdown cells, consistent with a role for pannexin-1 in IL-1b
secretion by primary GEC. All these results imply that a P2X4/
P2X7/pannexin-1 complex is required for IL-1b secretion in
response to ATP treatment of P. gingivalis-infected cells.
Discussion
Our results show that P2X4, P2X7, and pannexin-1 contribute
to ROS generation and are associated with inflammasome
activation in GEC. Consistent with this possibility, previous
studies have suggested that P2X4 and P2X7 may behave as
heteromeric receptors on bone marrow derived macrophages
(BMDM) [54,55]. Similarly, ATP-induced cell death of mouse
macrophages was shown to involve the P2X4 receptor, initiating
Ca2+ influx upon stimulation with ATP and contributing to pore
formation by activation of the P2X7 receptor [56,57]. These
findings suggest the functionality and dependence of the P2X4 and
P2X7 receptors on each other.
In GEC, we found that extracellular nucleotide-induced ROS
production occurred within a few minutes and was specific for
ATP stimulation. We then characterized expression of possible
target receptors and tested whether specific inhibitors for these
receptors could block ROS generation. Inhibitors of P2X4, P2X7,
and pannexin-1 reduced significantly ATP-dependent production
of ROS. To further evaluate the functionality of the receptors, we
depleted either purinergic receptor or pannexin-1 by RNA
interference, and find that both purinergic receptors and
pannexin-1 are required for efficient ATP-induced ROS produc-
tion in primary or immortalized GEC. Our findings differ from
another study, which showed that depletion of the P2X4 receptor
increased ATP-mediated ROS production in the macrophage cell
line, RAW264.7 cells [56,57]. The conflicting results may be
attributed to different cells lines, but we also used primary GEC
and found similar results as with the HIGK cells.
It has been proposed that either DAMPs or PAMPs could
trigger ROS production, which leads to NLRP3 inflammasome
activation [19]. However, the intracellular origin of ROS remains
debated. Previous studies demonstrated that inhibiting NADPH
oxidases with pharmacological inhibitors such as DPI or depletion
by siRNA significantly decreased caspase-1 activity and IL-1b
maturation in macrophages stimulated with DAMPs or PAMPS,
indicating that NADPH oxidase-elicited ROS play a role in
inflammasome activation [47,58–60]. Subsequently, another
intracellular source of ROS, mitochondria, was also reported to
activate NLRP3 in response to DAMPs or PAMPs by inducing
oxidation and release of mitochondrial DNA [30,61,62]. In GECs,
a recent study demonstrated that ATP stimulation results in
NADPH-induced ROS generation via P2X7 ligation which also
promotes mROS generation, indicating that NADPH oxidase and
mitochondria produce ROS synergistically [45]. Consistent with
these findings, we showed that inhibition of NADPH oxidiase also
decreased oATP-induced mROS generation.
Our studies show that that pannexin-1 is indispensable for ATP-
induced NLRP3 activation in GECs. However, recent genetic
evidence showed normal NLRP3 inflammasome function in
macrophages derived from Panx1-deficient mice [63,64]. This
discrepancy may be explained by assuming that pannexin-1 plays
a different role in different cell types. For example, in neurons,
pannexin-1 is involved in inflammasome-induced cell death, as
shown through the use of pannexin-1 depletion and Panx1-
deficient mice [65–67].
We have previously reported that treatment of GEC with ATP
concentrations that stimulate P2X7 leads to activation of the
inflammasome and caspase-1 [39]. However, we now find that
depletion of either P2X4 or P2X7 results in decreased caspase-1
activation in GEC. ROS is produced when either P2X4 or P2X7
are stimulated, but caspase-1 is activated only when GEC are
treated with ATP concentrations that activate P2X7. Similarly, IL-
1b secretion from P. gingivalis-infected cells, which requires
caspase-1 activation, could be induced by treatment of the
infected cells with ATP concentrations that stimulate P2X7, but
inhibiting or depleting either P2X4 or P2X7 resulted in
significantly lower levels of IL-1b secretion.
Taken together, these results suggested that P2X4 stimulation
may not be sufficient for activation of caspase-1, but P2X4 may
form a complex with P2X7, which could explain why P2X4
depletion results in loss of P2X7-mediated signaling. We confirmed
this hypothesis by demonstrating by co-immunprecipitation
experiments that P2X4 is physically associated with P2X7 and
pannexin-1 in GEC. P2X4 and P2X7 have previously been shown
to also form heteromeric receptors in BMDM [54]. Thus, these
results suggest that P2X7 stimulation is required for caspase-1
activation, but P2X4, through its presence in the P2X4/P2X7/
pannexin-1 complex, modulates the activity of P2X7 (Figure 7).
Here, we provide an initial insight into how signaling through
P2X4, P2X7, and pannexin-1 may activate caspase-1 in GEC. The
same complex is involved in secretion of IL-1b from GEC that had
been primed by P. gingivalis infection. Thus, understanding the
triggers for P2X72dependent ROS generation and caspase-1
activation could aid in drug discovery and development of
therapeutic approaches for diseases associated with P. gingivalis,
such as periodontal disease and cardiovascular disease.
An obvious question is the intracellular source of ROS in GEC
following P2X4 or P2X7 stimulation, which could be from
mitochondria and/or the NADPH oxidase on the plasma
membrane [34]. A larger challenge may be to identify the
molecular mechanisms that allow caspase-1 to be activated only
after P2X7 stimulation, even though both P2X4 and P2X7 ligation
leads to ROS production.
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